Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
Stroke 37:852-858, Thomalla,G.,et al, 2006
Imaging-Guided Acute Ischemic Stroke Therapy: From "Time is Brain" to "Physiology is Brain"
AJNR 27:728-735, Gonzalez,R.G., 2006
Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006
Intracranial Dural Arteriovenous Fistulas with Retrograde Cortical Venous Drainage: Assessment with Cerebral Blood Volume by Dynamic Susceptibility Contrast Magnetic Resonance Imaging
AJNR 27:1252-1256,1257, Noguchi,K.,et al, 2006
Multiple Sclerosis: The Role of MR Imaging
AJNR 27:1165-1176, Ge,Y., 2006
Early Clinical Signs and Imaging Findings in Gerstmann-Straussler-Scheinker Syndrome (Pro102Leu)
Neurol 66:1672-1678, Arata,H.,et al, 2006
Is Penumbral Imaging Useful for Extending the Treatment Window for Intravenous Tissue Plasminogen Activator?
Ann Neurol 60:499-501, Fisher,M., 2006
Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005
The role of radiotracer imaging in Parkinson disease
Neurol 64:208-215, Ravina, B., et al, 2005
The Pathophysiology of Watershed Infarction in Internal Carotid Artery Disease
Stroke 36:567-577, Momjian-Mayor, I. & Baron, J-C., 2005
Tissue at Risk is Overestimated in Perfusion-Weighted Imaging: MR Imaging in Acute Stroke Patients Without Vessel Recanalization
AJNR 26:815-819, Kucinski,T.,et al, 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005
Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy
Arch Neurol 62:721-728, Mega,M.S.,et al, 2005
Incidence of Contrast Nephropathy From Cerebral CT Angiography and CT Perfusion Imaging
Neurol 64:1805-1806, Josephson,S.A.,et al, 2005
[99mTc]TRODAT-1 SPECT Imaging Correlates with Odor Identification in Early Parkinson Disease
Neurol 64:1716-1720, Siderowf,A.,et al, 2005
Lesion Size Determines Accuracy of Thallium-201 Brain Single-Photon Emission Tomography in Differentiating Between Intracranial Malignancy and Infection in AIDS Patients
AJNR 26:1973-1979, Younhg,R.J.,et al, 2005
Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005
Clinical Features and Diagnosis of Primary Central Nervous System Lymphoma
Hematol Oncol Clin North Am 19:689-703, Fitzsimmons,A.,et al, 2005
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke 36:66-73, Hacke,W.,et al, 2005
Diffusion-weighted and Perfusion MRI Demonstrates Parenchymal Changes in Complex Partial Status Epilepticus
Brain 128:1369-1376, Szabo, K.,et al, 2005
Early MRI Findings in Patients Receiving Tissue Plasminogen Activator Predict Outcome: Insights into the Pathophysiology of Acute Stroke in the Thrombolysis Era
Ann Neurol 55:105-112, Chalela,J.A.,et al, 2004
Computed Tomographic Angiography for Diagnosis of Brain Death
Neurol 62:652-653, Qureshi,A.I.,et al, 2004
Correlation of Quantitative EEG in Acute Ischemic Stroke with 30-Day NIHSS Score
Stroke 35:899-903, Finnigan,S.P.,et al, 2004
Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004
Basal Ganglia Hyperperfusion in a Patient with Systemic Lupus Erythematosus-Related Parkinsonism
Neurol 63:395-396, Lee,P.H.,et al, 2004
The Clinical-DWI Mismatch
Neurol 62:2187-2192, Davalos,A.,et al, 2004
Idiopathic Hyposmia As a Preclinical Sign of Parkinson's Disease
Ann Neurol 56:173-181,169, Ponsen,M.M.,et al, 2004
Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?
Stroke 35:2099, Fiehler,J.,et al, 2004
Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004
Assessment of Transient Ischemic Attack with Diffusion- and Perfusion-Weighted Imaging
AJNR 25:1645-1652, Restrepo,L.,et al, 2004
Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke
Stroke 34:575-583, Schellinger,P.D.,et al, 2003
Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003
[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003
Assessing Tissue Viability with MR Diffusion and Perfusion Imaging
AJNR 24:436-443, Schaefer,P.W.,et al, 2003
Safety and Feasibility of a CT Protocol for Acute Stroke: Combined CT, CT Angiography, and CT Perfusion Imaging in 53 Consecutive Patients
AJNR 24:688-690, Smith,W.S.,et al, 2003
Guidelines and Recommendations for Perfusion Imaging in Cerebral Ischemia
Stroke 34:1084-1104, Latchaw,R.E.,et al, 2003
Differences in the Diagnostic Accuracy of Acute Stroke Clinical Subtypes Defined by Multimodal Magnetic Resonance Imaging
JNNP 74:886-888,840, Allder,S.J.,et al, 2003
Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue
Stroke 34:1425-1430, Shih,L.C.,et al, 2003
Reliability of Assessing Percentage of Diffusion-Perfusion Mismatch
Stroke 34:1681-1685, Coutts,S.B.,et al, 2003
Prediction of Malignant Middle Cerebral Artery Infarction by Early Perfusion- and Diffusion- Weighted Magnetic Resonance Imaging
Stroke 34:1892-1900, Thomalla,G.J.,et al, 2003
Beyond Mismatch
Stroke 34:2729-2735, Kidwell,C.S.,et al, 2003
Primary Progressive Aphasia--A Language-Based Dementia
NEJM 349:1535-1542, Mesulam,M.-M., 2003
Measurement of the Ischemic Penumbra With MRI: It's About Time
Stroke 34:2533-2534, Warach,S., 2003
Acute Intravenou-Intra-Arterial Revascularization Therapy for Severe Ischemic Stroke
Stroke 33:279-282, Hill,M.D.,et al, 2002
Thrombolysis in Stroke Beyond Three Hours: Targeting Patients With Diffusion and Perfusion MRI
Ann Neurol 51:11-13,28, Warach,S., 2002
Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke
Stroke 33:1437-1441, Ringleb,P.A.,et al, 2002
The Stroke Patient Who Woke Up
Stroke 33:988-993, Fink,J.N.,et al, 2002
Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002
Prognostic Accuracy of Cerebral Blood Flow Measurement by Perfusion Computed Tomography, at the Time of Emergency Room Admission, in Acute Stroke Patients
Ann Neurol 51:417-432,415, Wintermark,M.,et al, 2002